Search

Additional file 1: Table S1. Multivariable Fine–Gray proportional hazards analysis of the relationship between patient-reported outcomes and mortality in waitlisted patients, excluding those who underwent living-donor lung lobar transplantation after registration.

Additional file 1. List of pulmonary disease in transplant candidates in the study.

Additional file 3: Table S2. Multivariable Fine–Gray proportional hazards analysis of the relationship of LAS and patient-reported outcomes with mortality in patients waiting for lung transplantation.

Additional file 1: Supplemental Table 1. Patients’ characteristics at the time of transplant and lung transplant recipients with/without DSA (n = 93). Supplemental Table 2. Transplant surgery and years since transplant in lung transplant recipients with/without DSA (n = 93). Supplemental Table 3. Possible risk factors of sensitization (n = 93) and HLA mismatch (n = 53). Supplemental Table 4. The association of CLAD with/without DSA in those who survived one year after lung transplant (n = 84). Supplemental Table 5. Cause of death and possible antibody mediated rejection among transplant patients who have passed away (n = 30).